Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.675 USD | -2.66% | +1.42% | -43.73% |
14/05 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
09/05 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.73% | 479M | |
+69.54% | 62.86B | |
-0.75% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.48% | 26.46B | |
-22.41% | 18.9B | |
+4.65% | 12.67B | |
+24.05% | 12.27B | |
+28.11% | 12.07B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Morgan Stanley Upgrades Editas Medicine to Equal-Weight From Underweight